Cargando…
SOX17 is a tumor suppressor in endometrial cancer
β-catenin is a key regulatory factor for the Wnt signaling pathway. SOX17 is an important β-catenin inhibitor, while MAML3 is a co-activator of β-catenin-mediated transcription. Out of 120 endometrial cancer (EC) patients, we found that those with tumors expressing higher SOX17 (n=68) had longer rec...
Autores principales: | Zhang, Yongli, Bao, Wei, Wang, Kai, Lu, Wen, Wang, Huihui, Tong, Huan, Wan, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342796/ https://www.ncbi.nlm.nih.gov/pubmed/27738313 http://dx.doi.org/10.18632/oncotarget.12582 |
Ejemplares similares
-
SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line
por: Zhang, Yongli, et al.
Publicado: (2016) -
SOX17 Inhibits Tumor Metastasis Via Wnt Signaling In Endometrial Cancer
por: Zhou, Weiqiang, et al.
Publicado: (2019) -
DICER1 regulates endometrial carcinoma invasion via histone acetylation and methylation
por: Li, Bilan, et al.
Publicado: (2017) -
Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations
por: Walker, Christopher J., et al.
Publicado: (2017) -
Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA
por: Chen, Guofang, et al.
Publicado: (2020)